Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate anti-oxidative and anti-inflammatory effects of
pitavastatin in hypercholesterolemic patients with the metabolic syndrome.